BIO-key International, Inc.
BKYI
$0.71
-$0.03-3.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.67% | 5.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.67% | 5.58% | |||
| Cost of Revenue | -22.88% | 66.08% | |||
| Gross Profit | -3.33% | -7.16% | |||
| SG&A Expenses | -16.68% | 22.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.19% | 23.71% | |||
| Operating Income | 17.69% | -69.20% | |||
| Income Before Tax | 17.35% | -58.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.35% | -58.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.35% | -58.51% | |||
| EBIT | 17.69% | -69.20% | |||
| EBITDA | 17.16% | -81.24% | |||
| EPS Basic | 26.93% | -28.03% | |||
| Normalized Basic EPS | 26.98% | -27.99% | |||
| EPS Diluted | 26.93% | -28.03% | |||
| Normalized Diluted EPS | 26.98% | -27.99% | |||
| Average Basic Shares Outstanding | 13.17% | 23.79% | |||
| Average Diluted Shares Outstanding | 13.17% | 23.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||